| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |